Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Tonini

Showing results (121-130 of 218) with videos related to

Pageof 22
Sort By:
Journal of Clinical Pathology|October 29, 2005
Tumour proliferation, angiogenesis, and ploidy status in human colon cancerE Cristi, G Perrone, G Toscano, et al.
Diabetologia|August 9, 2011
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetesD Iafusco, C Bizzarri, F Cadario, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
The use of SAMe in chemotherapy-induced liver injuryB Vincenzi, A Russo, A Terenzio, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|June 9, 1998
[Reliability of data of hospital discharge and anatomo-pathological records for population cancer registration]A Rossi, P Vincenti, F Donato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2006
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patientsB Vincenzi, D Santini, A Russo, et al.
British Journal of Cancer|October 17, 2003
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancerF Graziano, D Santini, E Testa, et al.
Transplantation Proceedings|June 1, 1988
Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantationS Savoldi, F Scolari, S Sandrini, et al.
Panminerva Medica|November 24, 2006
Geometry and bone densityG Radetti, F Rigon, G Tonini, et al.
Minerva Pediatrica|July 14, 2004
HyperparathyroidismG Tonini, L Tatò, F Rigon, et al.
Minerva Pediatrica|November 2, 1999
[Biologically inactive growth hormone]M Bozzola, F Buzi, C De Sanctis, et al.
Pageof 22

Showing results (121-130 of 218) with videos related to

Sort By:
Pageof 22
Journal of Clinical Pathology|October 29, 2005
Tumour proliferation, angiogenesis, and ploidy status in human colon cancerE Cristi, G Perrone, G Toscano, et al.
Diabetologia|August 9, 2011
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetesD Iafusco, C Bizzarri, F Cadario, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
The use of SAMe in chemotherapy-induced liver injuryB Vincenzi, A Russo, A Terenzio, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|June 9, 1998
[Reliability of data of hospital discharge and anatomo-pathological records for population cancer registration]A Rossi, P Vincenti, F Donato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2006
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patientsB Vincenzi, D Santini, A Russo, et al.
British Journal of Cancer|October 17, 2003
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancerF Graziano, D Santini, E Testa, et al.
Transplantation Proceedings|June 1, 1988
Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantationS Savoldi, F Scolari, S Sandrini, et al.
Panminerva Medica|November 24, 2006
Geometry and bone densityG Radetti, F Rigon, G Tonini, et al.
Minerva Pediatrica|July 14, 2004
HyperparathyroidismG Tonini, L Tatò, F Rigon, et al.
Minerva Pediatrica|November 2, 1999
[Biologically inactive growth hormone]M Bozzola, F Buzi, C De Sanctis, et al.
Pageof 22